|
1
|
Stewart BW and Wild CP: World Cancer
Report 2014. Lyon, France, IARC Press, 2014.
|
|
2
|
Rawla P, Sunkara T and Barsouk A:
Epidemiology of colorectal cancer: Incidence, mortality, survival,
and risk factors. Prz Gastroenterol. 14:89–103. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ohhara Y, Fukuda N, Takeuchi S, Honma R,
Shimizu Y, Kinoshita I and Dosaka-Akita H: Role of targeted therapy
in metastatic colorectal cancer. World J Gastrointest Oncol.
8:642–655. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kalyan A, Kircher S, Shah H, Mulcahy M and
Benson A: Updates on immunotherapy for colorectal cancer. J
Gastrointest Oncol. 9:160–169. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer-related inflammation, the seventh hallmark
of cancer : Links to genetic instability. Carcinogenesis.
30:1073–1081. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Peng L, Zhou Y, Wang Y, Mou H and Zhao Q:
Prognostic significance of COX-2 immunohistochemical expression in
colorectal cancer: A meta-analysis of the literature. PLoS One.
8(e58891)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Skierucha M, Milne AN, Offerhaus GJ,
Polkowski WP, Maciejewski R and Sitarz R: Molecular alterations in
gastric cancer with special reference to the early-onset subtype.
World J Gastroenterol. 22:2460–2474. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Terada T: An immunohistochemical study of
primary signet-ring cell carcinoma of the stomach and colorectum:
II Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and
in 42 cases. Int J Clin Exp Pathol. 6:613–621. 2013.PubMed/NCBI
|
|
9
|
Niv Y: MUC1 and colorectal cancer
pathophysiology considerations. World J Gastroenterol.
14:2139–2141. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zeng Y, Zhang Q, Zhang Y, Lu M, Liu Y,
Zheng T, Feng S, Hao M and Shi H: MC1 predicts colorectal cancer
metastasis: A systematic review and meta-analysis of case
controlled studies. PLoS One. 10(e0138049)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nath S, Roy LD, Grover P, Rao S and
Mukherjee P: Mucin 1 regulates Cox-2 gene in pancreatic cancer.
Pancreas. 44:909–917. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sitarz R, Leguit RJ, de Leng WW, Polak M,
Morsink FM, Bakker O, Maciejewski R, Offerhaus GJ and Milne AN: The
COX-2 promoter polymorphism-765 G>C is associated with
early-onset, conventional and stump gastric cancers. Mod Pathol.
21:685–690. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Eminaga O, Wei W, Hawley SJ, Auman H,
Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave
ME, et al: MUC1 Expression by immunohistochemistry is associated
with adverse pathologic features in prostate cancer: A
multi-institutional study. PLoS One. 11(e0165236)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kim SH, Ahn BK, Paik SS and Lee KH:
Cyclooxygenase-2 expression is a predictive marker for late
recurrence in colorectal cancer. Gastroenterol Res Pract.
2018(7968149)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kasprzak A, Siodla E, Andrzejewska M,
Szmeja J, Seraszek-Jaros A, Cofta S and Szaflarski W: Differential
expression of mucin 1 and mucin 2 in colorectal cancer. World J
Gastroenterol. 24:4164–4177. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Duncan TJ, Watson NF, Al-Attar AH,
Scholefield JH and Durrant LG: The role of MUC1 and MUC3 in the
biology and prognosis of colorectal cancer. World J Surg Oncol.
5(31)2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Betge J, Schneider NI, Harbaum L,
Pollheimer MJ, Lindtner RA, Kornprat P, Ebert MP and Langner C:
MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: Expression
profiles and clinical significance. Virchows Arch. 469:255–265.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu F, Liu F, Zhao H, An G and Feng G:
Prognostic significance of mucin antigen MUC1 in various human
epithelial cancers: A meta-analysis. Medicine (Baltimore).
94(e2286)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Baldus SE, Monig SP, Hanisch FG, Zirbes
TK, Flucke U, Oelert S, Zilkens G, Madejczik B, Thiele J, Schneider
PM, et al: Comparative evaluation of the prognostic value of MUC1,
MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal
adenocarcinoma. Histopathology. 40:440–449. 2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Krishn SR, Kaur S, Sheinin YM, Smith LM,
Gautam SK, Patel A, Jain M, Juvvigunta V, Pai P, Lazenby AJ, et al:
Mucins and associated O-glycans based immunoprofile for
stratification of colorectal polyps: Clinical implication for
improved colon surveillance. Oncotarget. 8:7025–7038.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kim JJ and Khan WL: Goblet cells and
mucins: Role in innate defense in enteric infections. Pathogens.
2:55–70. 2013.PubMed/NCBI View Article : Google Scholar
|
